← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Patient Centeredness in Hepatitis C Direct-Acting Antiviral Treatment Delivery to People Who Inject Drugs: A Scoping Review. (2021/09/01) ♡
• Reduction of Shear Wave Elastography but Not Shear Wave Dispersion After Successful Hepatitis C Treatment With Direct-Acting Antiviral Agents. (2021/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Chronic liver disease and oxidative stress - a narrative review. (2021/09/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Sofosbuvir-based regimens for HCV in stage 4-stage 5 chronic kidney disease. A systematic review with meta-analysis. (2021/09/01) ♡
• Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients. (2021/09/01) ♡
• Concurrent treatment of HIV, disseminated Mycobacterium avium complex and HCV-infection. (2021/08/31) ♡
• Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis. (2021/08/27) ♡
• Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017. (2021/08/27) ♡
• Medicaid Subscription-Based Payment Models and Implications for Access to Hepatitis C Medications. (2021/08/27) ♡
• Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use. (2021/08/27) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Vitamin D supplementation for chronic liver diseases in adults. (2021/08/25) ♡
• Comparison of hepatitis C treatment outcomes between telehepatology and specialty care clinics in the era of direct-acting antivirals. (2021/08/01) ♡
• Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients. (2021/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Liver Pathology, Including MOC31 Immunohistochemistry, in Congenital Tufting Enteropathy. (2021/08/01) ♡
• Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C. (2021/08/01) ♡
• The association between hepatitis C virus infection and renal function. (2021/08/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers. (2021/08/01) ♡
• Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016). (2021/07/13) ♡
• Changes of esophageal varices in hepatitis C patients after achievement of a sustained viral response by direct-acting antivirals. (2021/07/05) ♡
• Low Prevalence of Vaccination or Documented Immunity to Hepatitis A and Hepatitis B Viruses Among Individuals with Chronic Liver Disease. (2021/07/01) ♡
• Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis. (2021/07/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study. (2021/07/01) ♡
• [Prevalence of viral hepatitis type C in blood donors in Peru 2016 - 2017]. (2021/07/01) ♡
• Metabolic Impact of Diabetes Mellitus Type 2 in Hepatitis C Virus Infected Patients. (2021/07/01) ♡
• Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C. (2021/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications. (2021/06/10) ♡
• Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis. (2021/06/08) ♡
• Direct acting antiviral therapy rescues neutrophil dysfunction and reduces hemolysis in hepatitis C infection. (2021/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnosis and management of secondary causes of steatohepatitis. (2021/06/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. (2021/05/21) ♡
• Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. (2021/05/01) ♡
• Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes. (2021/05/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers. (2021/05/01) ♡
• Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study. (2021/05/01) ♡
• Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence. (2021/05/01) ♡
• Iliopsoas Impingement After Direct Anterior Approach Total Hip Arthroplasty: Epidemiology, Risk Factors, and Treatment Options. (2021/05/01) ♡
• Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. (2021/05/01) ♡
• Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan. (2021/04/28) ♡
• Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome. (2021/04/03) ♡
• Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients. (2021/04/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current and future strategies for the treatment of chronic hepatitis C. (2021/04/01) ♡
• Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma. (2021/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis C: clinical management and debated issues. (2021/04/01) ♡
• Cognitive impairment in children with chronic Hepatitis C Virus: Case control study. (2021/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs. (2021/04/01) ♡
• Serum MicroRNAs as predictors for fibrosis progression and response to direct-acting antivirals treatment in hepatitis C virus genotype-4 Egyptian patients. (2021/04/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Response to letter to the editor "The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma". (2021/04/01) ♡
• Burden of Liver Cirrhosis in Portugal between 2010 and 2017. (2021/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis C virus-related cryoglobulinemic vasculitis. (2021/04/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection. (2021/04/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.